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ABSTRACT
Background: The characteristics of the ideal type of
mesh are still being debated. Mesh shrinkage and fixation
have been associated with complications. Avoiding
shrinkage and fixation would improve hernia recurrence
rates and complications. To our knowledge, this is the first
study of a device with a self-expanding frame for laparo-
scopic hernia repair.
Methods: Six Rebound Hernia Repair Devices were
placed laparoscopically in pigs. This device is a con-
densed polypropylene, super-thin, lightweight, macro-
porous mesh with a self-expanding Nitinol frame. The
devices were assessed for adhesions, shrinkage, and his-
tological examination. Laboratory and radiologic evalua-
tions were also performed.
Results: The handling properties of the devices facilitated
their laparoscopic placement. They were easily identified
with simple x-rays. The mesh was firmly integrated within
the surrounding tissue. One device was associated with 3
small adhesions. The other 5 HRDs had no adhesions. We
noted no shrinkage or folding. All devices preserved their
original size and shape.
Conclusions: At this evaluation stage, we found that the
Rebound Hernia Repair Device may serve for laparo-
scopic hernia repair and has favorable handling proper-
ties. It prevents folding and shrinkage of the mesh. It may
eliminate the need for fixation, thus preventing chronic
pain. The Nitinol frame also allowed radiologic evaluation
for gross movement. Further studies will be needed to
evaluate its clinical application.
Key Words: Hernia, Laparoscopic hernia repair, Mesh,
Pig.
INTRODUCTION
Hernia repair techniques using mesh have been associ-
ated with hernia recurrence rates that are up to 50% lower
compared with those for tissue-to-tissue sutured hernia
repair. Numerous experiments have sought the ideal mesh
for laparoscopic hernia repair, but this question is still
unanswered. By far, the most widely used material is
polypropylene (PP). Prosthetics made from PP induce
biologic reactivity, which varies depending on their
weight, filament size, pore size, and architecture of the
prosthetic, as well as on the individual host response.
Heavyweight PP meshes have properties that lead to ex-
cellent fibrous ingrowth but also may induce a brisk fi-
brous reaction and tissue ingrowth into the mesh. It has
been demonstrated that decreasing the amount of bioma-
terial content of mesh reduces inflammatory response and
shrinkage.1 To reduce the inflammatory response, the
trend has been to use lighter weight, more porous PP
mesh that enhances the formation of a scar net rather than
a scar plate. The type and amount of material and the
structure of the mesh are also of critical importance for the
development of adhesions.1–3 Further optimization of
mesh materials is still needed.4,5
The optimal method for mesh fixation has been debated.
Mechanical anchorage of the mesh is intended not only to
reduce mesh migration, shrinkage, and folding, but also to
enhance the bursting strength of the repair.6,7 The main
concern about mesh fixation is the development of
chronic pain.8–10 Pain might be due to nerve entrapment
associated with the use of sutures or staplers. The poten-
tial complications of mesh fixation and the risk of mesh
folding or migration have led to the consideration of
alternative methods. The ideal mesh should have good
biocompatibility coupled with good handling properties.
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SCIENTIFIC PAPERIn our study, we evaluated the Rebound Hernia Repair
Device (HRD) in pigs. The Rebound HRD uses a Nitinol
(Nickel Titanium Naval Ordinance Laboratory) frame to
make a self-expanding support for the mesh. The objec-
tives included evaluating laparoscopic deployment of the
device, verifying the device location with postoperative
x-rays, and evaluating the shape, hernia recurrence rates,
tissue ingrowth, and changes in the area surrounding the
implant and hernia defect.
MATERIALS AND METHODS
Experimental Protocol
The use and care of all the pigs in our study were in
accordance with the Guide for the Care and Use of Lab-
oratory Animals (National Institute of Health publication
No. 86–23). The protocol was approved by the Institu-
tional Animal Care and Use Committee (IACUC) of the
University of Minnesota. This investigation was conducted
in compliance with the regulations for Good Laboratory
Practice for Nonclinical Laboratory Studies (21 CFR [Code
of Federal Regulations] 58). The study was monitored by
an independent quality assurance unit. All procedures
were conducted at the Experimental Surgical Services of
the University of Minnesota.
We gave antibiotics to 3 female adult pigs (weight range
49 kg to 57 kg) and monitored their preoperative
health. Their scheduled survival time postoperatively
was 90 days. We implanted 2 Rebound HRDs bilaterally
in the preperitoneal space of each pig. Immediately
after implantation and on postoperative days 7, 30, 60,
and 90, we obtained x-rays. A complete blood count
was obtained before surgery, on the day of implanta-
tion, and at sacrifice. At 90 days, necropsies were per-
formed and tissue blocks containing the patches were
explanted. A radiographic image of each device was
made in a Faxitron 805 x-ray system (Field Emission
Corp., McMinnville, OR) to evaluate the shape of the
devices.
Mesh Types and Characteristics
Rebound HRD (Minnesota Medical Development, Inc.,
Minneapolis MN) are made with a condensed PP, super-
thin, lightweight, macroporous mesh. It has 2 different
shapes: the Hybrid Small (8.81 cm x 11.28 cm) and the
Dog Bone (7.65 cm x 10.24 cm). Both have a PP mesh
with a pore size of 2410 m, a thickness of 250 m, and
a density of 52.0 g/m
2.
The devices have a self-expanding multistrand Nitinol frame
designed mainly for the laparoscopic repair of both inguinal
and ventral hernias. The mesh is tied to the Nitinol frame by
a polyethylene polyblend braided suture. The superelastic
Nitinol frame allows the device to be folded and inserted
laparoscopically by using the loading cannula through a
10-mm port. The HRDs can also be folded and placed via a
small incision. Once deployed, it fully unfurls or “rebounds”
back to its original shape and conforms to the patient’s
preperitoneal anatomy. Before implantation, the device was
evaluated for magnetic resonance (MR) safety by using a
3-Tesla MR system (General Electric Healthcare, Milwaukee,
WI). The Rebound HRD was recognized as the 2006 Inno-
vation of the Year by the Society of Laparoendoscopic Sur-
geons (SLS) (SLS does not endorse or approve any products).
Operative Technique
Before anesthesia induction, each pig received Telazol
(tiletamine-zolazepam) at 6 mg/kg and xylazine hydro-
chloride at 1.2 mg/kg. Anesthesia was induced with 1
mg/kg to 2 mg/kg of propofol intravenously; additional
amounts were given if needed. The animals were intu-
bated, and mechanical ventilation was maintained with 4
liters per minute of O2 and isoflurane (1.5% to 2%). Ceft-
iofur at 5 mg/kg and gentamicin at 3 mg/kg were used for
antibiotic coverage and Buprenorphine at 0.03 mg/kg was
administrated as an analgesic.
Implantation of the devices was accomplished laparo-
scopically. With the pig in the supine position, pneumo-
peritoneum was established with a Veress needle. Two
5-mm trocars and one 10-mm trocar were placed.
Two hernia defects were made bilaterally on the abdom-
inal wall of each pig. First, the peritoneum was incised
with a Harmonic scalpel (Ethicon Endo-Surgery, Inc., Cin-
cinnati, OH, USA) to perform a preperitoneal dissection.
Then, the fascia was incised to create a hernia defect. After
that, the devices were introduced into the abdominal
cavity via the 10-mm trocar using the Rebound HRD
10-mm loading cannula.
The devices were positioned to cover the defect with at
least 1cm beyond the border of the defect circumferen-
tially. The mesh side of the devices (opposite to the
Nitinol frame) was placed adjacent to the fascia. The
devices were not sutured to surrounding tissue. The peri-
toneum was sutured over the devices with 2–0 Vicryl
(Ethicon, Inc., Somerville, NJ), and 2 or 3 Ligaclips (Ethi-
con Endo-Surgery, Inc., Cincinnati, OH, USA) were ap-
plied in the peritoneum to complete the closure. For all 3
animals, each hernia repair proceeded independently of
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the first hernia repair was completed). Each animal re-
ceived 2 Rebound HRD: 1 Dog Bone shape (Figure 1),
and the other a Hybrid Small (Figure 2) shape. Because
the peritoneum in the inguinal area of the pig was very
thin and difficult to suture, the hernia site was advanced
proximally according to the quality of the peritoneum.
Only 1 of the HRDs was placed in the inguinal area. One
of the pigs had the device placed invertedly on the mesh
side, to ascertain the effects of improper orientation. The
trocars were removed under direct vision, and the skin
was closed. The handling and laparoscopic deployment
was also evaluated.
Immediately after surgery, we obtained baseline postop-
erative x-rays to document the position of the HRDs. All
animals were observed on a daily basis. Postoperative
medications included amoxicillin/clavulanate at 14 mg/
kg, twice a day for 7 days to 10 days (for antibiotic
prophylaxis) and buprenorphine at 0.03 mg/kg intramus-
cularly or subcutaneously as needed (for analgesic ther-
apy).
Necropsy and Radiological Evaluation
Postoperatively x-rays were performed immediately after
implantation and at 7, 30, 60, and 90 days. The pig was
placed in the supine ventral-dorsal abdominal position.
We used an x-ray 903, type B-85 portable large animal
veterinary unit (MinXRay Inc., Northbrook, IL). We used
bony landmarks (pelvis and spinal column) as references
for potential movement of the device.
The pigs were euthanized 90 days after the HRDs were
implanted. Prior to euthanasia, the animals were given
Telazol (tiletamine and zolazepam) at 6 mg/kg and Xyla-
zine at hydrochloride 1.2 mg/kg IM. After approximately 5
minutes, we administered 300 units/kg of heparin IV. The
pigs were then euthanized with an IV injection of Beutha-
nasia-D (pentobarbital sodium and phenytoin sodium)
solution at 1 mL/5kg to 10 kg.
At necropsy, adhesion areas and the dimensions of the
mesh were measured in the fresh specimen. The HRDs
were removed with at least 2.5 cm of normal tissue at its
margins. In the fresh specimen, the shape and area of the
devices were evaluated. To assess shape and area with the
greatest accuracy, we used the Faxitron. We recorded
descriptive features and photographic images, and then
fixed the specimens in 10% neutral buffered formalin
(NBF).
After fixation for at least 48 hours, we obtained a radio-
graphic image of each HRD in a Faxitron (40 KVP for 1.5
min). We trimmed a minimum of 6 sites and processed
them for histologic examination by routine procedures,
staining them with hematoxylin and eosin (H&E) and
Masson’s trichrome. Samples from the cable coupling site
and the cable-mesh-thread site were collected for embed-
ding in methylmethacrylate, then ground and stained with
H&E and Masson’s trichrome. A complete blood count
was obtained before surgery, on the day of implantation,
Figure 1. Dog Bone Shape Rebound HRD with 10-mm loading
cannula.
Figure 2. Hybrid Small Shape Rebound HRD with 10-mm load-
ing cannula.
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ries in Marshfield, WI.
RESULTS
Surgery, Radiologic and Laboratory Evaluation
We performed all of the laparoscopic deployments of the
HRDs without complications. Their handling properties
facilitated their placement. The Nitinol frame prevented
folding and allowed easy manipulation of the mesh into
the abdomen. Only the first HRD of the first pig was
implanted in the inguinal area (Figure 3); the remaining
HRDs were implanted proximal to the inguinal area (Fig-
ure 4).
The HRDs were easily identified on the radiographic
prints (Figure 4). However, evaluating the potential
movement of the HRDs was difficult because of the in-
consistency in the pigs’ positioning between radiography
time points, along with their fast growth rate and size.
Slight discrepancies in rotation and position between the
time points decreased the usefulness of bony landmarks
as references, but still we did not find any gross move-
ment of any of the HRDs. The shape of the mesh was
completely preserved.
The MR evaluation showed that the HRD was safe. It was
considered “MR-conditional” according to the terminology
specified by the American Society for Testing and Materi-
als.11–14 A patient with this HRD could be scanned safely,
immediately after placement. All the parameters of the
complete blood count were within normal limits, with no
difference in the mean values at the 3 evaluation time
points.
Necropsy and Histologic Findings
All 3 pigs were in good health, and their weights were 115
kg, 108 kg, and 106 kg. Of the 6 HRDs implanted, 5 were
in appropriate sites, covering the hernias with a margin of
more than 1.5 cm. In 1 implantation site, the border of the
mesh was slightly 1 cm from the hernia margin. It was
not easy to determine whether the mesh migrated after the
procedure or whether it was implanted “off center” during
surgery. Because, the largest amount of mature fibrous
tissue was located at the center of the HRD, it would seem
more likely that the implantation of the device was “off
center.” If migration did occur, then the HRD moved very
slightly ventrally.
Figure 3. Supine ventral-dorsal abdominal x-ray. The device on
the left (Dog Bone Shape) is implanted in the inguinal area; the
device on the right (Hybrid Small Shape) is implanted proximal
to the inguinal area.
Figure 4. Supine ventral-dorsal abdominal x-ray immediately
after surgery. In the right abdominal wall is a Small Hybrid
Rebound HRD. In the left side is a Dog Bone Rebound HRD.
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men and with the Faxitron, their shape and area were
preserved (Figure 5). The mesh held firmly to the Nitinol
frame and was flat and unwrinkled. The peritoneal surface
of the HRD placed in the inguinal area had 3 band-
adhesions of about 1.5 mm in diameter, 2 of them to the
urinary bladder and 1 to the spiral colon. The peritoneum
covering the mesh in this area had some small sites where
the suturing was not able to completely close the gap
between the 2 peritoneal edges. It was difficult to evaluate
whether the adhesions were caused by incomplete peri-
toneal coverage. However, the HDRs and the wound
surface were all completely covered by mesothelium. No
intraabdominal adhesions were associated with the other
HRDs. No lesions were detected in any organ. The mesh
was firmly integrated within the surrounding tissue. Each
individual fiber was surrounded by connective tissue and
covered with peritoneum.
The microscopic slides showed the mesh firmly integrated
within the surrounding tissue (Figure 6). The mesh was
embedded in mature fibrous tissue of variable thickness
(0.2 mm to 4 mm) and was separated from the peritoneal
surface by fibrous tissue and histiocytes. The sites of the
coupling-thread-mesh complex seemed to stimulate the
thickest fibrous reaction, with sites up to 4-mm thick
(Figure 6). The host tissue response to the cable-mesh-
thread junction site was a mild fibrogranulomatous reac-
tion with a narrow layer of histiocytes and occasional
multinucleated giant cells adjacent to the HRD and fibro-
blasts at the periphery.
Small nodules of osseous metaplasia were present in
some areas associated with the fibrous tissue. The size of
the nodules varied (0.5 mm to 5 mm). Small nodules
formed by the Ligaclips on the peritoneum surface (Fig-
ure 7). They were about 3 mm to 4 mm in diameter and
covered with fibrous tissue. These Ligaclips were used to
assist with the peritoneal closure; they were not part of the
HRDs. We intentionally implanted 1 HRD upside down;
We found no discernible difference in that HRD outcome
compared with outcome at the other sites.
DISCUSSION
The search continues for the ideal hernia repair. This
search has shifted away from discussing the type of repair
and has turned instead to an evaluation of the type of
mesh used in the repair.15 The characteristics of the ideal
type of mesh are still being debated. A better mesh should
show better biologic tolerance. To evaluate the biocom-
patibility of an implant, the mesh needs to fulfill its pre-
determined function, achieving a high level of tissue in-
corporation and causing as few local or systemic side
effects as possible.
Nevertheless, mesh always induces an inflammatory for-
eign-body reaction.16 This reaction might be associated
with a higher rate of chronic pain and local discomfort, in
relation to the amount of material in the mesh and its
surface structure. Heavyweight, small-pore mesh tends to
cause a more pronounced inflammatory reaction. In con-
trast, large-pore, lightweight mesh produces less inflam-
matory reaction and less scar formation.17,18
The size of the pores seems to be the main factor in
successful incorporation and diminished foreign-body re-
action. The structure of the mesh appears to be of greater
importance than the material itself in terms of adhesion
formation and mesh shrinkage.19 Incorporation of mesh
could be improved by enlarging mesh pores and by using
thinner fibers to have smaller knots and prevent the bridg-
ing effect.16 Pores 1,000 m produce a more physiologic
wound healing, avoiding scar overgrowth.20 Large pores
in the mesh allow the individual mesh fibers to become
incorporated in the neoperitoneum. Reducing the material
amount and increasing pore size have led to a consider-
able advancement in biocompatibility.4,15,17,18 On the
other hand, the reported theoretical advantages of light
meshes have been questioned in some prospective ran-
domized studies and some animal experiments.15,21 More-
over, some evidence suggests that reducing the material
amount leads to a greater risk of hernia recurrence.22
All available types of mesh, regardless of composition,
Figure 5. Fresh specimen with a Dog Bone Shape Rebound
HRD. The mesh is flat, unwrinkled, and completely covered by
mesothelium.
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implantation. Physiologic wound contraction has been
associated with considerable mesh shrinking and folding.
It is not the mesh itself that shrinks, rather, the surface
reduction is caused by connective tissue contraction dur-
ing the consolidation of scar tissue. The pronounced
shrinkage of heavyweight meshes appears to be of crucial
importance in hernia recurrence. Lightweight monofila-
ment large-pore PP mesh has less of a tendency to
shrink,15 thus reducing the theoretical risk of hernia re-
currence.
Even with the reduction in the material amount and with
the increase in pore size, mesh can still shrink consider-
ably.4,19 With large-pore mesh, the bridging effect is re-
duced and the shrinkage is also reduced,4 resulting in
more of a scar ‘‘net“ (rather than a scar ‘‘plate”). Some
authors have attributed shrinkage to the bridging effect. In
our study, the HRDs showed no shrinkage, a most desir-
able effect because of the known association between
shrinkage and hernia recurrence. The HRD with macro-
porous (2410m) mesh showed some bridging effect in
parts of the pathology samples. Independently of this
finding, the HRD did not show shrinking or folding, and
the mesh was always completely flat, maintaining its orig-
Figure 6. Frame coupling-mesh-thread
junction site methylmethacrylate (plastic)
embedded section stained with H&E. The
Rebound HRD is firmly integrated within
the surrounding mature fibrous tissue.
Figure 7. Fresh specimen with a Hybrid Small Shape Rebound
HRD. The peritoneum is covering the device completely. A small
nodule was formed by Ligaclips used to close the peritoneum.
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the mesh characteristics,1,17 but the most important factor
appeared to be the Nitinol frame that prevented the mesh
from shrinking. One of the reasons for hernia recurrence
after hernia repair has been mesh shrinkage. The Nitinol
frame might represent an advantage that could diminish
or eliminate mesh folding during the desufflation process,
considered an important factor for hernia recurrence.23
Long-term clinical studies investigating this aspect are,
however, currently not available.
Nitinol has been safely used and proven reliable in several
specialties, such as cardiac surgery, orthopedics, and in-
terventional radiology.28–30
Mesh shrinking has also been associated with inadequate
mesh fixation.19 Fixation is intended not only to reduce
mesh migration, shrinkage, and folding, but also to en-
hance the bursting strength of the repair.6,7 The Nitinol
frame has a good tensile strength that allows it to keep the
mesh in a constant shape, thus preventing shrinking. The
main complication associated with mechanical mesh fix-
ation is the development of chronic pain caused by nerve
entrapment. The elasticity of the Nitinol frame may allow
the HRDs to easily adjust to human anatomy, offering a
potential way to diminish the need for fixation and its
possible complications.
We found metaplasic bone in the fibrous tissue associated
with the HRDs. This was found mostly located in the area
of cutting and hernia creation site made by the Harmonic
scalpel and may have some association with the trauma
and the heat generated. Osseous metaplasia is a common
response to trauma and foreign material in the abdominal
wall of pigs.24–26 Calcifications have also been reported in
humans, mostly associated with long-term implantation of
heavyweight microporous mesh.27 The significance of this
finding is still to be determined.
The handling properties associated with the mesh are
important during laparoscopic placement. The consider-
able increase in flexibility of the lightweight macroporous
mesh makes it difficult for surgeons to handle or manip-
ulate it in the operating room.15 Some types of mesh
incorporate absorbable filaments into their weave, to add
stiffness and facilitate implantation, but doing so may
contribute to increased surface area and potentially to a
higher infection risk.15 In our study, we placed the HRDs
laparoscopically to reproduce, as closely as possible, the
conditions of laparoscopic hernia repair in human pa-
tients. The stabilization of the mesh and the stiffness
provided by the addition of the Nitinol frame remarkably
made it easy to handle.
The possibility of identifying the HRD with a simple x-ray
may represent a favorable property of this device. We
found that the exact position of the HRD was difficult to
evaluate, but its gross position and its shape were easily
evaluated.
On the basis of our results, we conclude that at this stage
of evaluation, the Rebound HRD may be suited for lapa-
roscopic hernia repair. It may help reduce or eliminate
shrinkage, which in the long-term may be associated with
other benefits. Its handling properties facilitated laparo-
scopic placement; the elimination of fixation should help
prevent chronic pain in the long term. The Nitinol frame
may represent an advantage in terms of radiologic evalu-
ation for gross movement, mesh shrinkage, and mesh
folding. Long-term clinical studies are needed to confirm
our favorable results in pigs with the Rebound HRD.
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